Fluor Corporation Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Fluor Corporation Common Stock trades at $51.11 (market cap $6.84B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Fluor Corporation Common Stock is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Fluor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fluor Corporation Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| FLR | RLAY | |
|---|---|---|
Market Cap | $6.84B | $3.94B |
Volume | 1,992,844 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $57.50 | $20.75 |
52-Week Low | $39.63 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.87B | $3.06B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Fluor provides engineering, procurement, construction, and maintenance services. It works across energy, infrastructure, mining, advanced technology, manufacturing, life sciences, and government projects.
Read more on FLR →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →